Will the Evolut Low Risk trial change my practice?

Chairpersons: H. Treede, S. Windecker

Session Reporter: C. O'Sullivan

Summary

Consult this session to learn all about the Evolut Low Risk TAVI trial, whose goal was to assess the safety and efficacy of transcatheter aortic valve replacement with the self-expanding CoreValve, compared with surgical aortic valve replacement in low-risk patients. Discover how its results apply to your practice!

Learning Objectives

To learn about the relevance of the Low Risk TAVI trials
To learn to which patients the results of the low risk TAVI trials apply
To put the trial findings into context of intermediate and high-risk trial results

Presentations available when logged in:

Introduction - the trial headlines
A representative case from the study: how should I treat?
What was known before the Low Risk TAVI trials
Trial(ist) review: methods, results, conclusions
Case conclusion: how does this apply to my practice

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Will the Evolut Low Risk trial change my practice?

Learning Objectives

Log in or create account for free